Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

Novavax news

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Tommy Yap 2025 Aug 09, 21:00

Week Ahead: RBA interest rate decision and US CPI data in focus

Forex Indices
Sophia Claire 2025 Aug 09, 02:20

Market Review: Gold, Oil, Geopolitics & Tariffs - A Comprehensive Overview

Ava Grace 2025 Aug 08, 15:20

Bitcoin Cycle Shift: A Look at the New Era of Institutional Dynamics & Regulation

Emma Rose 2025 Aug 08, 15:20

US and Russia Negotiating Ukraine Peace Deal: Will Conflict Be Frozen?

Noah Lee 2025 Aug 08, 13:20

Gold Futures Soar Amid Tariff Concerns: A Comprehensive Analysis

Emma Rose 2025 Aug 08, 10:20

Oil Price Stabilization: Impact of US Sanctions & Geopolitical Tensions

Ava Grace 2025 Aug 08, 08:20

Economists Warn Trump's BLS Firing Parallels Authoritarian Leaders

Ava Grace 2025 Aug 08, 06:05

Cambodia Nominates Trump for Nobel Peace Prize Over Thailand Border Conflict

Info

Spread

0.07

Spread (%)

0.8393 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1359472128

Shares Outstanding

162422000

Earnings Date (Next)

2019-05-10

instr__dividend_date

2019-05-10

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

EPS

2.22

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Trustpilot